Literature DB >> 22972937

Mixing of the old with the new: nanoparticle-mediated pioglitazone delivery to enhance therapeutic neovascularization.

Calvin C Sheng, Charles C Hong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22972937      PMCID： PMC3672409          DOI： 10.1161/ATVBAHA.112.300217

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  10 in total

1.  The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.

Authors:  Christoph Gensch; Yvonne P Clever; Christian Werner; Milad Hanhoun; Michael Böhm; Ulrich Laufs
Journal:  Atherosclerosis       Date:  2006-07-28       Impact factor: 5.162

Review 2.  A critical review of clinical arteriogenesis research.

Authors:  Niels van Royen; Jan J Piek; Wolfgang Schaper; William F Fulton
Journal:  J Am Coll Cardiol       Date:  2009-12-29       Impact factor: 24.094

3.  Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.

Authors:  Ryoji Nagahama; Tetsuya Matoba; Kaku Nakano; Shokei Kim-Mitsuyama; Kenji Sunagawa; Kensuke Egashira
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-09       Impact factor: 8.311

4.  PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.

Authors:  Dipak Panigrahy; Samuel Singer; Lucy Q Shen; Catherine E Butterfield; Deborah A Freedman; Emy J Chen; Marsha A Moses; Susan Kilroy; Stefan Duensing; Christopher Fletcher; Jonathan A Fletcher; Lynn Hlatky; Philip Hahnfeldt; Judah Folkman; Arja Kaipainen
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.

Authors:  T Murata; S He; M Hangai; T Ishibashi; X P Xi; S Kim; W A Hsueh; S J Ryan; R E Law; D R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

6.  Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.

Authors:  Y Fukunaga; H Itoh; K Doi; T Tanaka; J Yamashita; T H Chun; M Inoue; K Masatsugu; N Sawada; T Saito; K Hosoda; H Kook; M Ueda; K Nakao
Journal:  Atherosclerosis       Date:  2001-09       Impact factor: 5.162

7.  Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium.

Authors:  Mitsuki Kubo; Kensuke Egashira; Takahiro Inoue; Jun-ichiro Koga; Shinichiro Oda; Ling Chen; Kaku Nakano; Tetsuya Matoba; Yoshiaki Kawashima; Kaori Hara; Hiroyuki Tsujimoto; Katsuo Sueishi; Ryuji Tominaga; Kenji Sunagawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-26       Impact factor: 8.311

8.  Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.

Authors:  Po-Hsun Huang; Masataka Sata; Hiroaki Nishimatsu; Makoto Sumi; Yasunobu Hirata; Ryozo Nagai
Journal:  Biomed Pharmacother       Date:  2007-07-20       Impact factor: 6.529

9.  Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.

Authors:  Federico Biscetti; Eleonora Gaetani; Andrea Flex; Tamar Aprahamian; Teresa Hopkins; Giuseppe Straface; Giovanni Pecorini; Egidio Stigliano; Roy C Smith; Flavia Angelini; John J Castellot; Roberto Pola
Journal:  Diabetes       Date:  2008-02-11       Impact factor: 9.461

10.  In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems.

Authors:  Boitumelo Semete; Laetitia Booysen; Yolandy Lemmer; Lonji Kalombo; Lebogang Katata; Jan Verschoor; Hulda S Swai
Journal:  Nanomedicine       Date:  2010-03-15       Impact factor: 5.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.